Chronic pain affects over 50 million adults in the U.S. alone and is a leading cause of disability worldwide (Dahlhamer et al., 2018). Yet not all chronic pain is the same, and understanding what ...

Using their pain-on-a-chip method, the researchers were able to demonstrate the device's ability to objectively distinguish the response of the nociceptor cells towards the two chronic pain subtypes.

In A Nutshell Researchers identified CGRP-producing neurons in the thalamus that connect pain signals with emotional threat ...

Recent reports show that in 2016, 20.4% of United States adults had chronic pain that lasted three months or longer. That rose to 20.9% in 2021 and to 24.3% in 2023.

Hydragun looked at how chronic pain affects aspects of health including feelings of depression, sleep, and physical function, citing data from a University of Pittsburgh Medical Center study ...

But when guilt is suppressed, denied, or unprocessed, those pain signals can become chronic, creating physical symptoms that seem disconnected from their emotional source. This isn’t imaginary pain.

In 2023, 24.3% of U.S. adults had chronic pain lasting 3 months or longer. In 2016, that figure was 20.4%, and in 2021, it was 20.9%. The numbers came from the National Health Interview Survey ...

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades.. The drug, suzetrigine, is a 50-milligram prescription pill ...